Fluid removal in acute heart failure: Diuretics versus devices

Current Opinion in Critical Care

Volumn 20, Issue 5, 2014, Pages 478-483

  Krishnamoorthy, Arun ^a,b   Felker, G Michael ^a,b  

^a Duke University Trent Drive   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Acute heart failure; Diuretics; Fluid removal; Ultrafiltration

Indexed keywords

CREATININE; LOOP DIURETIC AGENT; DIURETIC AGENT;

ACUTE HEART FAILURE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DIURESIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW DRUG DOSE; MEDICAL DEVICE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; ULTRAFILTRATION; WEIGHT REDUCTION; ACUTE DISEASE; ADVERSE EFFECTS; BLOOD; COMPLICATION; HEART FAILURE; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES;

ACUTE DISEASE; CREATININE; DIURETICS; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; ULTRAFILTRATION; WEIGHT LOSS;

EID: 84925943977     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000134     Document Type: Review

References (33)

1. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from HHF registries. J Am Coll Cardiol 2014;63:1123-1133.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics: 2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
3. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128:3240-3327. This document is a recent, extensive update of consensus guidelines on the care of patients with heart failure.
4. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009;53:557-573.
5. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216.
6. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013;61:391-403.
7. Mentz RJ, Felker GM. Noncardiac comorbidities and acute heart failure patients. Heart Fail Clin 2013;9:359-367; vii.
8. O'Connor CM, Stough WG, Gallup DS, et al. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 2005;11:200-205.
9. Jentzer JC, De Wald TA, Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010;56:1527-1534.
10. Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 2012;59:2145-2153.
11. Brater DC. Update in diuretic therapy: clinical pharmacology. Semin Nephrol 2011;31:483-494.
12. Felker GM, O'Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2009;2:56-62.
13. Massie BM, O'Connor CM, Metra M, et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-1428.
14. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011;365:32-43.
15. Teerlink JR, Cotter G, Davison BA, et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebocontrolled trial. Lancet 2013;381:29-39. This manuscript details preliminary clinical trial results on the novel vasodilator serelaxin, a potential useful adjunct in the care of AHF patients.
16. Damman K, Valente MA, Voors AA, et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 2014;35:455-469. This meta-analysis thoroughly reviews the significance of chronic renal impairment and worsening renal function in patients with heart failure.
17. Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 2012;60:1031-1042.
18. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007;9:1064-1069.
19. Felker GM, Lee KL, Bull DA, et al. Diuretic Strategies in Patients with Acute Decompensated Heart Failure. N Engl J Med 2011;364:797-805.
20. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-596.
21. Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010;122:265-272.
22. Schneierson SJ. Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin. Am J Med Sci 1949;218:76-79.
23. Bart BA. Treatment of congestion in congestive heart failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. Circ Heart Fail 2009;2:499-504.
24. Marenzi G, Lauri G, Grazi M, et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-968.
25. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005;46:2043-2046.
26. Costanzo MR, Saltzberg MT, Jessup M, et al. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010;16:277-284.
27. Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012;367:2296-2304.
28. Bart BA, Goldsmith SR, Lee KL, et al. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail 2012;18:176-182.
29. Bart BA, Hernandez AF. Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med 2013;368:1159-1160.
30. Tang WHW. Reconsidering ultrafiltration in the acute cardiorenal syndrome. N Engl J Med 2012;367:2351-2352.
31. Costanzo MR, Fonarow GC, Filippatos GS. Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med 2013;368:1158-1159.
32. Bikdeli B, Strait KM, Dharmarajan K, et al. Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives? J Am Coll Cardiol 2013;61:1549-1550.
33. Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2009;2:370-376.